Product image of Latanoprost Viatris (Latanoprost) supplied by GNH India

Latanoprost Viatris

Active Ingredient:
Latanoprost
Origin:
EU

Latanoprost Viatris (Latanoprost)

Latanoprost, the active ingredient in Latanoprost Viatris, is a prostaglandin analog presented as an ophthalmic solution for ocular use. It is employed to lower intra‑ocular pressure in patients with open‑angle glaucoma or ocular hypertension, helping to preserve visual function. The medication is administered as a single drop in the affected eye(s) once daily, typically in the evening, to achieve consistent pressure control.

GNH India supplies Latanoprost Viatris as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Upjohn Eesv

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Latanoprost is a prostaglandin analog used in ocular hypotensive therapy to manage elevated eye pressure.
  • Open-angle glaucoma: reduces intra‑ocular pressure to slow disease progression.
  • Ocular hypertension: lowers eye pressure to prevent conversion to glaucoma.

How It Works

  • Latanoprost acts as an agonist of the prostaglandin F (FP) receptors located in the ciliary body and trabecular meshwork. Activation of FP receptors enhances uveoscleral outflow of aqueous humor, thereby decreasing intra‑ocular pressure. The drug’s structural similarity to endogenous prostaglandin F2α facilitates receptor binding and promotes remodeling of extracellular matrix components, contributing to sustained pressure reduction. This mechanism provides a once‑daily therapeutic effect with minimal systemic exposure.

Side Effects

Latanoprost may cause ocular and systemic reactions; reported events are categorized by frequency.

Common Side Effects

  • Eye redness: mild conjunctival hyperemia.
  • Iris darkening: gradual increase in brown pigmentation.
  • Eyelash growth: longer, thicker lashes.
  • Eye irritation: foreign body sensation or mild discomfort.

Serious or Rare Side Effects

  • Uveitis: inflammation of the uveal tract requiring medical attention.
  • Allergic reaction: swelling, itching, or rash around the eye.
  • Severe eye pain: may indicate corneal involvement.
  • Vision loss: rare but possible if intra‑ocular pressure drops excessively.

Precautions & Warnings

  • When prescribing Latanoprost, clinicians should consider several safety measures.
  • Monitor intra‑ocular pressure: assess response after initiation.
  • Assess for ocular allergies: discontinue if severe irritation occurs.
  • Avoid use in active eye infection: may exacerbate condition.
  • Inform patients about possible iris color change: usually permanent.
  • Store at room temperature: keep in original container, protect from light and moisture.

Avoid Interactions

Latanoprost can interact with other ophthalmic agents; awareness of interaction severity guides clinical decisions.

Major Interactions (Avoid)

  • Concurrent use with other prostaglandin analogs: additive ocular side effects and hyperpigmentation.
  • Combination with systemic carbonic anhydrase inhibitors: excessive intra‑ocular pressure reduction may lead to hypotony.

Moderate Interactions (Monitor Closely)

  • Co‑administration with topical non‑steroidal anti‑inflammatory drugs (NSAIDs): may diminish latanoprost efficacy.
  • Use with beta‑blocker eye drops (e.g., timolol): monitor for enhanced pressure‑lowering effect.
  • Interaction with ocular anesthetics: possible increased ocular discomfort.

Frequently Asked Questions

Latanoprost Viatris is a prescription ophthalmic solution that lowers intra‑ocular pressure in patients with open‑angle glaucoma or ocular hypertension, helping to prevent optic nerve damage and preserve vision.

Latanoprost binds to prostaglandin F (FP) receptors in the eye, stimulating the uveoscleral outflow pathway. This increased drainage of aqueous humor reduces intra‑ocular pressure, which is the primary therapeutic goal in glaucoma management.

The dosing regimen for Latanoprost Viatris is determined by the prescribing clinician. Typically, one drop is instilled in the affected eye(s) once daily, but the exact dose and timing should follow the prescriber’s instructions.

The safety of Latanoprost in pregnancy or while breastfeeding has not been definitively established. Healthcare providers should weigh potential benefits against unknown risks and consider alternative therapies when appropriate.

To request Latanoprost Viatris, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Latanoprost belongs to the prostaglandin analog class, which generally offers once‑daily dosing and strong intra‑ocular pressure reduction. Compared with beta‑blockers or carbonic anhydrase inhibitors, prostaglandin analogs often have a more favorable dosing convenience but may cause pigmentary changes in the eye.

Latanoprost Viatris should be stored at room temperature, below 25 °C, in its original container. Protect the product from light and moisture, and keep it out of reach of children.

Latanoprost is applied as an ophthalmic solution. The patient places one drop into the conjunctival sac of the affected eye(s) once daily, usually in the evening, and avoids touching the dropper tip to any surface to maintain sterility.

Serious risks, though rare, include uveitis, severe ocular pain, allergic reactions around the eye, and significant vision loss due to excessive pressure reduction. Patients should seek immediate medical attention if they experience any of these symptoms.

Latanoprost is contraindicated in patients with known hypersensitivity to latanoprost or any component of the formulation, and it should be used with caution in individuals with active ocular infections or inflammation.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Latanoprost

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT